No abstract available
MeSH terms
-
Advisory Committees
-
Diabetes Mellitus, Type 2 / drug therapy
-
Drug Labeling / legislation & jurisprudence*
-
Government Regulation
-
Humans
-
Hypoglycemic Agents / adverse effects*
-
Hypoglycemic Agents / therapeutic use
-
Meta-Analysis as Topic
-
Myocardial Ischemia / chemically induced*
-
Odds Ratio
-
PPAR gamma / metabolism
-
Pioglitazone
-
Product Recalls and Withdrawals
-
Research Design
-
Rosiglitazone
-
Thiazolidinediones / adverse effects*
-
Thiazolidinediones / therapeutic use
-
United States
-
United States Food and Drug Administration*
Substances
-
Hypoglycemic Agents
-
PPAR gamma
-
Thiazolidinediones
-
Rosiglitazone
-
Pioglitazone